Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Krka: ‘Quantities, Capacities No Problem’ As Firm Looks To €2bn Milestone
EBITDA Margin Of 27% Will Face Continued Pressures Krka Admits; Guidance For 25%
Feb 05 2025
•
By
Dean Rudge
• Source: Shutterstock
More from Earnings
More from Manufacturing